A lable-free SPR biosensor based on one peptide sequence with three recognition sites for O-GlcNAc transferase detection

Abnormal O-linked N-acetylglucosamine (O-GlcNAc) concentrations have been associated with many diseases, but the lack of accurate detection method limited O-GlcNAc to be used as a biomarker in clinical diagnosis. Then O-GlcNAc transferase (OGT) has drawn researchers' attention as it closed related to the level of O-GlcNAc and be considered to be a promising new target for diseases diagnosis. Nevertheless, the existing OGT detection methods are either need labeling or the sensitity can not meet the needs of clinic testing. Herein, a label-free and sensitive SPR biosensor was developed for accurate detection of OGT based on a multi-functional peptide. The designed peptide contains three recognition sites, one is the cleavage site of protease K, one is the O-GlcNAcylated site by OGT, and another is six histidine which be used as the signal report probe to recognize Ni2+. The immobilized peptide would be cleavaged by proteinase K, then the His-tag residue part will leave the surface of Au film, resulting less His-tag could bind to Ni2+ and a small SPR signal would be record. If the peptide is O-GlcNAcylated by OGT, the cleaving reaction would be limited due to the adjacent site of O-GlcNAcylation. Then more His-tag can be left on the Au film and a bigger SPR signal could be record, this signal is associated with the concentration of OGT. Utilizing the change of the peptide configuration as a signal report probe for OGT detection not only avoids labeling of peptide, but also makes the method more sensitive. The determination linear range of OGT is from 2.00 x 10(-13) to 5.00 x 10(-8) M with a detection limit of 1.19 x 10(-13) M, and the separation of two enzyme reactions ensured the high selectivity of the method. Finally, the sensing system was successfully used for OGT detection in blood samples with satisfied recovery. In summary, the label-free SPR platform for accurate detection of OGT in real samples is helpful to promote OGT serve as a biomarker for early clinical diagnosis of O-GlcNAc related diseases.

Automated summary

Abnormal O-GlcNAc concentrations have been linked to various diseases, but the lack of accurate detection methods has hindered its use as a biomarker in clinical diagnosis. OGT has emerged as a potential target for disease diagnosis due to its close relationship with O-GlcNAc levels. A label-free and sensitive SPR biosensor was developed for the accurate detection of OGT, utilizing a multi-functional peptide with three recognition sites. The method, which uses the change in peptide configuration as a signal probe, offers high sensitivity and selectivity, making it a promising tool for early clinical diagnosis of O-GlcNAc related diseases.